Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study
about
Effects of prostaglandin analogues on aqueous humor outflow pathways.Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment.Current primary open-angle glaucoma treatments and future directions.Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trialDemonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy.Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials.Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.
P2860
Q34393424-9FDD8194-4116-43DC-B092-6398FC868D4DQ35102806-13D379C3-3D94-4010-B9E9-7022CC942A53Q36214307-C58376E4-537B-45F6-97F8-54796B11563FQ36358734-A99D9E4F-DD5C-47F3-9E1D-08DBB8DB1731Q37030839-95B96F4F-E04E-4E1C-BF7D-F7A928BDD99EQ37918357-5BE086DF-18A0-4D85-8CE5-4168F4E3B297Q38582444-6B57C8B1-9F7E-42EC-BFF2-B2A87BC4607AQ39791012-9C34E60C-58F3-4625-8E09-81F4ECF8C305Q42943389-FC0E515C-1A13-419B-B841-070FFA90551B
P2860
Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and tolerability of b ...... d-evaluator, multicentre study
@en
Efficacy and tolerability of b ...... -evaluator, multicentre study.
@nl
type
label
Efficacy and tolerability of b ...... d-evaluator, multicentre study
@en
Efficacy and tolerability of b ...... -evaluator, multicentre study.
@nl
prefLabel
Efficacy and tolerability of b ...... d-evaluator, multicentre study
@en
Efficacy and tolerability of b ...... -evaluator, multicentre study.
@nl
P2093
P2860
P356
P1476
Efficacy and tolerability of b ...... d-evaluator, multicentre study
@en
P2093
D A Hollander
J A Kammer
S L Ackerman
P2860
P356
10.1136/BJO.2009.158071
P407
P577
2009-09-01T00:00:00Z